Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
51.14
+1.63
+(3.29%)
At close: 4:00:01 PM EST
51.14
0.00
(0.00%)
After hours: 4:20:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 318,308 | 35 |
| Sales | 188,019 | 22 |
| Net Shares Purchased (Sold) | 130,289 | 57 |
| Total Insider Shares Held | 1.01M | -- |
| % Net Shares Purchased (Sold) | 14.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SIEGAL JONATHAN DAVID Officer | Sale at price 52.07 per share. | Direct | 59,204 | Feb 25, 2025 |
| FLYNN SEAN C Officer | Sale at price 52.07 per share. | Direct | 86,905 | Feb 25, 2025 |
| SIEGAL JONATHAN DAVID Officer | -- | Direct | -- | Feb 24, 2025 |
| COLANGELO DOMINICK C Chief Executive Officer | -- | Direct | -- | Feb 24, 2025 |
| HOPPER JONATHAN MARK Officer | -- | Direct | -- | Feb 24, 2025 |
| HALPIN MICHAEL Chief Operating Officer | -- | Direct | -- | Feb 24, 2025 |
| FLYNN SEAN C Officer | -- | Direct | -- | Feb 24, 2025 |
| MARA JOSEPH ANTHONY JR Chief Financial Officer | -- | Direct | -- | Feb 24, 2025 |
| FLYNN SEAN C Officer | Sale at price 57.32 per share. | Direct | 219,822 | Feb 20, 2025 |
| SIEGAL JONATHAN DAVID Officer | Sale at price 56.72 per share. | Direct | 96,991 | Feb 19, 2025 |
| COLANGELO DOMINICK C Chief Executive Officer | -- | Direct | -- | Feb 19, 2025 |
| HOPPER JONATHAN MARK Officer | -- | Direct | -- | Feb 19, 2025 |
| HALPIN MICHAEL Chief Operating Officer | -- | Direct | -- | Feb 19, 2025 |
| FLYNN SEAN C Officer | -- | Direct | -- | Feb 19, 2025 |
| SIEGAL JONATHAN DAVID Officer | -- | Direct | -- | Feb 18, 2025 |
| MARA JOSEPH ANTHONY JR Chief Financial Officer | -- | Direct | -- | Feb 18, 2025 |
| MCLAUGHLIN KEVIN F Director | Sale at price 55.43 - 55.47 per share. | Direct | 388,250 | Feb 12, 2025 |
| MCLAUGHLIN KEVIN F Director | Conversion of Exercise of derivative security at price 2.76 - 3.74 per share. | Direct | 25,200 | Feb 12, 2025 |
| RUBINO ALAN L Director | Conversion of Exercise of derivative security at price 3.74 per share. | Direct | 71,060 | Feb 7, 2025 |
| SIEGAL JONATHAN DAVID Officer | Sale at price 61.99 per share. | Direct | 67,693 | Feb 5, 2025 |
| ZERBE ROBERT L Director | Sale at price 62.50 per share. | Direct | 156,250 | Feb 5, 2025 |
| ZERBE ROBERT L Director | Conversion of Exercise of derivative security at price 13.05 per share. | Direct | 32,625 | Feb 5, 2025 |
| SIEGAL JONATHAN DAVID Officer | Conversion of Exercise of derivative security at price 48.80 per share. | Direct | 53,290 | Feb 5, 2025 |
| SIEGAL JONATHAN DAVID Officer | Sale at price 61.99 per share. | Direct | 242,257 | Jan 28, 2025 |
| SIEGAL JONATHAN DAVID Officer | Conversion of Exercise of derivative security at price 48.80 per share. | Direct | 190,710 | Jan 28, 2025 |
| HOPPER JONATHAN MARK Officer | Stock Award(Grant) at price 54.91 per share. | Direct | 7,083 | Dec 31, 2024 |
| HALPIN MICHAEL Chief Operating Officer | Stock Award(Grant) at price 35.91 - 54.91 per share. | Direct | 13,999 | Dec 31, 2024 |
| MARA JOSEPH ANTHONY JR Chief Financial Officer | Stock Award(Grant) at price 35.91 - 54.91 per share. | Direct | 6,463 | Dec 31, 2024 |
| WOTTON PAUL K Director | Sale at price 58.72 per share. | Direct | 152,672 | Dec 4, 2024 |
| HOPPER JONATHAN MARK Officer | Sale at price 58.72 per share. | Direct | 587,200 | Dec 2, 2024 |
| HOPPER JONATHAN MARK Officer | Conversion of Exercise of derivative security at price 16.66 per share. | Direct | 166,600 | Dec 2, 2024 |
| ZERBE ROBERT L Director | Sale at price 60.00 per share. | Direct | 150,000 | Nov 22, 2024 |
| ZERBE ROBERT L Director | Conversion of Exercise of derivative security at price 13.05 per share. | Direct | 32,625 | Nov 22, 2024 |
| COLANGELO DOMINICK C Chief Executive Officer | Sale at price 53.93 - 55.57 per share. | Direct | 1,916,250 | Nov 14, 2024 |
| COLANGELO DOMINICK C Chief Executive Officer | Conversion of Exercise of derivative security at price 3.02 per share. | Direct | 105,700 | Nov 14, 2024 |
| MCLAUGHLIN KEVIN F Director | Sale at price 55.54 per share. | Direct | 388,780 | Nov 13, 2024 |
| MCLAUGHLIN KEVIN F Director | Conversion of Exercise of derivative security at price 3.74 per share. | Direct | 26,180 | Nov 13, 2024 |
| ZERBE ROBERT L Director | Sale at price 55.00 - 57.50 per share. | Direct | 281,250 | Nov 12, 2024 |
| ZERBE ROBERT L Director | Conversion of Exercise of derivative security at price 13.05 per share. | Direct | 65,250 | Nov 12, 2024 |
| COLANGELO DOMINICK C Chief Executive Officer | Sale at price 40.34 - 41.38 per share. | Direct | 1,430,100 | Oct 17, 2024 |
| COLANGELO DOMINICK C Chief Executive Officer | Conversion of Exercise of derivative security at price 3.02 per share. | Direct | 105,700 | Oct 17, 2024 |
| HAGEN HEIDI Director | Conversion of Exercise of derivative security at price 3.74 per share. | Direct | 37,400 | Oct 17, 2024 |
| GILMAN STEVEN C Director | Sale at price 41.36 per share. | Direct | 241,253 | Oct 16, 2024 |
| GILMAN STEVEN C Director | Conversion of Exercise of derivative security at price 13.05 per share. | Direct | 76,121 | Oct 16, 2024 |
| GILMAN STEVEN C Director | Sale at price 40.35 per share. | Direct | 235,362 | Oct 2, 2024 |
| GILMAN STEVEN C Director | Conversion of Exercise of derivative security at price 13.05 per share. | Direct | 76,121 | Oct 2, 2024 |
| SIEGAL JONATHAN DAVID Officer | Sale at price 41.90 per share. | Direct | 23,799 | Oct 1, 2024 |
| FLYNN SEAN C Officer | Stock Award(Grant) at price 35.91 per share. | Direct | 1,760 | Sep 30, 2024 |
| SIEGAL JONATHAN DAVID Officer | -- | Direct | -- | Sep 30, 2024 |
| GILMAN STEVEN C Director | Sale at price 45.54 per share. | Direct | 265,680 | Sep 18, 2024 |
Related Tickers
RYTM Rhythm Pharmaceuticals, Inc.
53.22
+1.56%
MIRM Mirum Pharmaceuticals, Inc.
45.22
-1.67%
ACLX Arcellx, Inc.
65.63
+4.79%
XENE Xenon Pharmaceuticals Inc.
36.02
+0.64%
MRUS Merus N.V.
44.64
-1.83%
MDWD MediWound Ltd.
16.32
-4.06%
KRYS Krystal Biotech, Inc.
175.22
+1.97%
AGIO Agios Pharmaceuticals, Inc.
33.39
+0.82%
EWTX Edgewise Therapeutics, Inc.
24.50
-4.03%
RVMD Revolution Medicines, Inc.
37.96
-0.99%